Supernus Pharmaceuticals | SUPN - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Abbott USD 8.52B 1.01B 2025-12
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Aurora Cannabis CAD 95.69M 44.47M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 298.06M 171.86M 2025-09
Cara Therapeutics USD 20.65M 13.57M 2025-06
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
United Therapeutics USD 1.56B 217M 2025-12
Xeris Pharmaceuticals USD 91.6M 32.32M 2025-09